Skip to main content
. 2013 Dec;17(12):898–909. doi: 10.1089/gtmb.2013.0223

Table 4.

WMDS (95% CIs) and I2 for Various Contrasts of IL-6 −174G/C Polymorphism and Bone Mineral Density

 
 
 
CC vs. GG
CG vs. GG
CC vs. CG
CC+CG vs. GG
CC vs. CG+GG
BMD Populationa No. of studies (sample size) WMD (95% CI) I2(%) WMD (95% CI) I2(%) WMD (95% CI) I2(%) WMD (95% CI) I2(%) WMD (95% CI) I2(%)
Femoral neckb
Overall   11 (7596) 0.001 (0.001 to 0.001)c 26.2 0.007 (−0.003 to 0.017) 50.4d −0.002 (−0.002 to −0.002)c 0.0 0.008 (−0.002 to 0.017) 49.7d −0.001 (−0.001 to −0.000)c 0.0
Subgroup European 8 (5601) 0.001 (0.001 to 0.001)c 41.3 0.010 (−0.006 to 0.026) 65.7d −0.002 (−0.002 to −0.002)c 0.0 0.010 (−0.004 to 0.024) 63.4d −0.001 (−0.001 to −0.000)c 0.0
  Female 9 (6761) 0.001 (0.001 to 0.001)c 0.0 0.005 (−0.005 to 0.014) 42.8d −0.002 (−0.002 to −0.002)c 0.0 0.002 (0.002 to 0.003)c 36.5 −0.001 (−0.001 to −0.000)c 0.0
  Postmenopausal 7 (5690) 0.001 (0.001 to 0.001)c 0.0 0.003 (0.003 to 0.003)c 28.2 −0.002 (−0.002 to −0.002)c 0.0 0.002 (0.002 to 0.003)c 1.7 −0.001 (−0.001 to −0.000)c 0.0
  High quality 10 (7370) 0.001 (0.001 to 0.001)c 32.7 0.006 (−0.004 to 0.016) 51.7d −0.002 (−0.002 to −0.002)c 0.0 0.007 (−0.002 to 0.016) 51.0d −0.001 (−0.001 to −0.000)c 0.0
Lumbar spineb,e
Overall   9 (3032) 0.011 (−0.009 to 0.031) 39.8 0.007 (−0.009 to 0.022) 37.9 0.007 (−0.011 to 0.026) 0.0 0.007 (−0.007 to 0.021) 40.7 0.015 (−0.001 to 0.031) 0.0
Subgroup European 8 (2581) 0.011 (−0.009 to 0.031) 39.8 0.007 (−0.009 to 0.022) 37.9 0.007 (−0.011 to 0.026) 0.0 0.007 (−0.007 to 0.021) 40.7 0.010 (−0.008 to 0.027) 0.0
  Female 8 (2942) 0.003 (−0.018 to 0.024) 0.0 0.003 (−0.013 to 0.019) 32.5 0.004 (−0.016 to 0.023) 0.0 0.003 (−0.011 to 0.017) 17.9 0.011 (−0.006 to 0.028) 0.0
  Postmenopausal 7 (2687) −0.003 (−0.027 to 0.020) 0.0 −0.002 (−0.021 to 0.018) 39.5 0.001 (−0.021 to 0.023) 0.0 −0.002 (−0.019 to 0.014) 15.6 0.009 (−0.010 to 0.027) 4.7
  High quality 7 (2450) 0.017 (−0.020 to 0.053) 58.2d 0.010 (−0.017 to 0.037) 56.6d 0.007 (−0.013 to 0.027) 0.0 0.008 (−0.015 to 0.032) 55.9d 0.014 (−0.003 to 0.032) 37.8
Trochanterb
Overall   6 (2716) 0.013 (−0.001 to 0.026) 34.4 0.012 (0.002 to 0.021)c 0.0 0.001 (−0.012 to 0.014) 0.0 0.011 (0.002 to 0.020)c 22.6 0.006 (−0.006 to 0.018) 19.4
Subgroup European 3 (721) 0.018 (−0.003 to 0.039) 58.6 0.018 (0.003 to 0.033)c 55.8 −0.001 (−0.021 to 0.019) 0.0 0.012 (−0.013 to 0.036) 62.0d 0.007 (−0.012 to 0.026) 3.2
  Female 5 (1971) 0.019 (0.004 to 0.034)c 0.0 0.013 (0.002 to 0.024)c 8.7 0.006 (−0.009 to 0.020) 0.0 0.013 (0.003 to 0.023)c 27.2 0.012 (−0.002 to 0.025) 0.0
  Postmenopausal 3 (900) 0.013 (−0.009 to 0.035) 24.2 0.007 (−0.008 to 0.023) 0.0 0.006 (−0.015 to 0.027) 40.6 0.006 (−0.008 to 0.020) 0.0 0.009 (−0.011 to 0.029) 43.4
Total hip
Overall   5 (4793) 0.000 (−0.000 to 0.000) 33.4 0.004 (0.004 to 0.004)c 47.5 −0.004 (−0.004 to −0.004)c 0.0 0.009 (−0.004 to 0.023) 56.1d −0.002 (−0.003 to −0.002)c 0.0
Subgroup European 4 (4359) 0.000 (−0.000 to 0.000) 40.9 0.010 (−0.007 to 0.027) 60.6d −0.004 (−0.004 to −0.004)c 0.0 0.010 (−0.007 to 0.028) 66.8d −0.002 (−0.003 to −0.002)c 0.0
  Postmenopausal 4 (4538) 0.000 (−0.000 to 0.000) 0.0 0.004 (0.004 to 0.004)c 0.0 −0.004 (−0.004 to −0.004)c 0.0 0.003 (0.003 to 0.003)c 0.0 −0.002 (−0.003 to −0.002)c 0.0
  High quality 4 (4437) 0.000 (−0.000 to 0.000) 48.2 0.009 (−0.006 to 0.025) 60.5d −0.004 (−0.004 to −0.004)c 0.0 0.010 (−0.006 to 0.027) 67.0d −0.002 (−0.003 to −0.002)c 1.5
Whole body
Overall   4 (1681) 0.015 (−0.005 to 0.035) 55.4d 0.012 (−0.008 to 0.032) 70.8d 0.006 (−0.006 to 0.018) 0.0 0.013 (−0.006 to 0.032) 71.6d 0.008 (−0.003 to 0.019) 0.0
Subgroup Female 3 (1591) 0.007 (−0.006 to 0.019) 42.1 0.007 (−0.013 to 0.028) 73.6d 0.006 (−0.007 to 0.018) 0.0 0.008 (−0.010 to 0.027) 71.9d 0.006 (−0.005 to 0.017) 0.0
  Postmenopausal 2 (1336) 0.035 (0.012 to 0.059)c 0.0 0.024 (0.007 to 0.042)c 0.0 0.009 (−0.012 to 0.031) 0.0 0.027 (0.010 to 0.043)c 0.0 0.020 (−0.000 to 0.041) 0.0
Ward's triangleb
Overall   4 (1910) 0.020 (−0.002 to 0.042) 32.5 0.020 (0.004 to 0.035)c 0.0 −0.000 (−0.021 to 0.021) 32.4 0.017 (0.003 to 0.032)c 0.0 0.008 (−0.012 to 0.029) 42.0
Subgroup Female 3 (1165) 0.035 (0.006 to 0.064)c 0.0 0.020 (−0.001 to 0.040) 0.0 0.015 (−0.013 to 0.043) 0.0 0.019 (0.001 to 0.037)c 0.0 0.023 (−0.003 to 0.050) 0.0
Distal radius
Overall   3 (4003) 0.008 (0.008 to 0.008)c 0.0 0.003 (0.003 to 0.003)c 0.0 0.005 (0.005 to 0.005)c 0.0 0.004 (0.004 to 0.005)c 0.0 0.006 (0.006 to 0.006)c 0.0
Middle radius
Overall   3 (1061) 0.007 (−0.004 to 0.018) 0.0 0.006 (−0.002 to 0.014) 0.0 0.001 (−0.010 to 0.011) 0.0 0.007 (−0.001 to 0.014) 0.0 0.003 (−0.007 to 0.013) 0.0
Ultradistal radius
Overall   3 (1061) 0.005 (−0.006 to 0.016) 0.0 0.004 (−0.004 to 0.012) 0.0 0.002 (−0.009 to 0.012) 0.0 0.004 (−0.003 to 0.012) 0.0 0.003 (−0.007 to 0.013) 0.0
a

All studies recruited European populations at whole body and distal radius; all subjects were women at the total hip, distal radius, middle radius, and ultradistal radius; all studies were classified as high quality at the trochanter, whole body, Ward's triangle, distal radius, middle radius, and ultradistal radius.

b

Only the difference for CC/CG versus GG was included in one study (Fontova et al., 2002).

c

Significant results, p-value<0.05.

d

Significant between-study heterogeneity (p<0.10), random-effects model was used.

e

Only the difference for CC versus CG/GG was included in one study (Ferrari et al., 2003).